High fitness level may decrease risk of colorectal, lung cancers
the ONA take:
According to a new study published online in JAMA Oncology, researchers from the University of Vermont in Burlington, Vermont, have found that men with a high fitness level in midlife may have a lower risk for developing colorectal and lung cancer.
For the study, researchers identified 13,949 men who had a baseline fitness exam where cardiorespiratory fitness (CRF) was assessed and had Medicare data of lung, prostate, and colorectal cancer diagnoses. Results showed that during a mean follow-up of 6.5 years, 1,310 were diagnosed with prostate cancer, 200 with lung cancer, and 181 with colorectal cancer.
The researchers found that those who had a high CRF during midlife had a 55% decreased risk of lung cancer and a 44% decreased risk of colorectal cancer compared with men with low CRF. Those with high CRF did not have a decreased risk for prostate cancer.
Researchers also found that men with high CRF in midline had a 32% decreased risk of cancer death among those who were diagnosed with colorectal, lung, or prostate cancer when they were older compared with men with low CRF.
Men with high CRF in midlife had a 68% decreased risk of cardiovascular disease-associated death compared with men with low CRF who developed cancer.
Men with a high fitness level in midlife may have a lower risk for developing colorectal and lung cancer.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
- Increased Diabetes Risk Associated With Cancer Development
- Childhood Neuroblastoma Survivors at Risk for Psych Impairment
- Drug Classification of Trastuzumab
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|